Geron reported $122.07M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Amgen USD 57.32B 2.72B Mar/2026
Bio Techne USD 200M 0 Jun/2026
Cassava Sciences USD 0 0 Dec/2024
Cytokinetics USD 1.29B 4.48M Mar/2026
Exelixis USD 165.93M 3.61M Jun/2026
Genmab DKK 5.35B 5.2B Mar/2026
Geron USD 122.07M 74K Mar/2026
Gilead Sciences USD 22.17B 2.76B Mar/2026
Incyte USD 38.27M 1.16M Jun/2026
MacroGenics USD 36.51M 500K Mar/2026
Novartis USD 49.01B 2.02B Jun/2026
Novavax USD 233.31M 4.23M Sep/2024